Sykon Capital »

Akebia Therapeutics shares owned by Sykon Capital

Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Sykon Capital from 13F filings

Historical chart of Sykon Capital investment in Akebia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akebia Therapeutics held by Sykon Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akebia Therapeutics by Sykon Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $28k 15k 1.83
2023-12-31 $19k 15k 1.24
2023-09-30 $17k 15k 1.14

More positions owned by Sykon Capital

Select Sector Spdr Tr Technology (XLK)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Invesco Exch Traded Fd Tr Ii S&p500 Low Vol (SPLV)
Ishares Tr Core S&p500 Etf (IVV)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Select Sector Spdr Tr Financial (XLF)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Ishares Tr Msci Eafe Etf (EFA)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Pacer Fds Tr Swan Sos Mod Jan (PSMD)
Select Sector Spdr Tr Indl (XLI)
Select Sector Spdr Tr Communication (XLC)
Spdr Ser Tr Bloomberg Invt (FLRN)

View all positions for Sykon Capital

Top funds holding Akebia Therapeutics

Satter Management
Vanguard Group
Acadian Asset Management
Susquehanna International
Millennium Management
BlackRock
Qube Research & Technologies
Jacobs Levy Equity Management
Geode Capital Management
Connor, Clark & Lunn Investment Management
Federated Investors
Assenagon Asset Management
FMR
Citadel Advisors
Eudaimonia Asset Management

View all funds holding Akebia Therapeutics